Overview
Local Subfascial and Intramuscular Tranexamic Acid Administration in Pediatric Patient Undergoing Scoliosis Surgery, Double Blind Randomized Control Trial
Status:
Not yet recruiting
Not yet recruiting
Trial end date:
2021-12-29
2021-12-29
Target enrollment:
0
0
Participant gender:
All
All
Summary
We hypothesized that local administration of tranexamic acid will minimize blood loss and blood product administration in pediatric patient undergoing scoliosis surgeryPhase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Cairo UniversityTreatments:
Tranexamic Acid
Criteria
Inclusion Criteria:- Children aged 2-12 years
- Of both sexes
- American society of anesthesiologist (ASA) physical status classification class I
- Undergoing general anesthesia for scoliosis surgery
Exclusion Criteria:
- Parents' refusal of regional block
- Known allergy to tranexamic acid
- Bleeding disorders (INR >1.4,Platelet count< 75000)